PARP1 and diffuse large B-cell lymphoma: Interestingly, the pro-apoptotic protein BIM (Fig. 2d), showed some increase with romidepsin in DLBCL cell lines (Toledo and Ly03), which was in agreement with the PARP1 cleavage pattern detected with romidepsin treatment.